As Frontiers Health approaches, we’re featuring interviews with members of the steering committee to give you a sneak peek of what to expect in Milan. Interested in signing up?
Back in January, pharmaphorum caught up with the Syneos Health team to discuss their experience and insights into the emerging category of digital therapeutics (DTx), and the use of softwar
AstraZeneca’s Calquence has been shown to improve progression-free survival in previously untreated mantle cell lymphoma (MCL), with an unprecedented trend towards improved overall survival